FDA Related News

Human Drugs

CGMP Violations at Guangzhou Baiyunshan

FDA warns Chinas Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd. about CGMP violations in its production of finished drugs.

Federal Register

Enhancing Diversity in Pediatric Drug Development Workshop

Federal Register notice: FDA announces a 9/6 public workshop entitled Enhancing Diversity in Therapeutics Development for Pediatric Patients to discus...

Human Drugs

Man Sentenced for Misbranded Drugs

The Justice Department says a Virginia man who pleaded guilty to distributing misbranded drugs via the Internet has been sentenced to two years in fed...

Medical Devices

Reclassify Some Oncology Panels: Petition

Foundation Medicine petitions FDA to reclassify all next-generation sequencing oncology panel devices used for somatic or germline variant detection t...

Human Drugs

FDA accepts Cabometyx sNDA for Pancreatic Tumors

FDA accepts for review an Exelixis supplemental NDA for Cabometyx (cabozantinib) and its use for treating certain adults with pancreatic and extra-pan...

Medical Devices

CDRH Health Equity Discussion Paper

CDRH publishes a discussion paper to seek public feedback on the issue of health equity in the context of medical devices.

Human Drugs

Bill Introduced to Spur Pediatric Rare Disease Studies

Senators Jack Reed (D-RI) and Shelley Moore Capito (R-WV) introduce a bipartisan bill entitled Innovation in Pediatric Drugs Act (S 4905) that would a...

Medical Devices

Smiths Medical Software Correction for Infusion Pumps

Smiths Medical corrects software used in its CADD-Solis and CADD-Solis VIP Ambulatory Infusion Pumps due to many issues that may occur if the device i...

Loper Bright May End FDA Speech Ban: Attorney

Reed Smith attorney James Beck says companies hit by FDA for off-label promotion may challenge the agencys reasoning under the new Loper Bright Suprem...

Medical Devices

Medtronic Recalls Nerve Monitor

Medtronic recalls (Class 1) its NIM Vital Nerve Monitoring System to conduct a product correction due to reports of false negative responses.